Technical Analysis for HROW - Harrow Health, Inc.

Grade Last Price % Change Price Change
grade D 5.05 -1.17% -0.06
HROW closed down 1.17 percent on Friday, August 23, 2019, on 36 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical HROW trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -1.17%
Oversold Stochastic Weakness -1.17%
Calm After Storm Range Contraction -5.96%
Wide Bands Range Expansion -5.96%
Oversold Stochastic Weakness -5.96%
Calm After Storm Range Contraction -1.94%
NR7 Range Contraction -1.94%

Older signals for HROW ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.
Health Pharmaceutical Pharmaceuticals Infectious Diseases Pharmacy Pharmaceutical Industry In China Pharmaceutical Sciences Drug Therapies
Is HROW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.99
52 Week Low 2.22
Average Volume 357,634
200-Day Moving Average 5.8676
50-Day Moving Average 7.1096
20-Day Moving Average 6.4435
10-Day Moving Average 5.507
Average True Range 0.4924
ADX 40.61
+DI 8.4482
-DI 31.3757
Chandelier Exit (Long, 3 ATRs ) 6.7028
Chandelier Exit (Short, 3 ATRs ) 6.1022
Upper Bollinger Band 8.5316
Lower Bollinger Band 4.3554
Percent B (%b) 0.17
BandWidth 64.812602
MACD Line -0.6365
MACD Signal Line -0.4699
MACD Histogram -0.1666
Fundamentals Value
Market Cap 101.32 Million
Num Shares 20.1 Million
EPS -0.81
Price-to-Earnings (P/E) Ratio -6.23
Price-to-Sales 1.39
Price-to-Book 4.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.53
Resistance 3 (R3) 5.58 5.46 5.45
Resistance 2 (R2) 5.46 5.34 5.44 5.42
Resistance 1 (R1) 5.26 5.27 5.20 5.21 5.40
Pivot Point 5.14 5.14 5.12 5.12 5.14
Support 1 (S1) 4.94 5.02 4.88 4.89 4.70
Support 2 (S2) 4.82 4.95 4.80 4.68
Support 3 (S3) 4.62 4.82 4.65
Support 4 (S4) 4.57